Evidence map›Paper›PMID 40390945›Full record

ArticleJournal of obstetrics and gynaecology of India2025

Pre-invasive Lesion of Cervix Among Healthy and Immune Compromised Individuals Using Histopathological Examination: A Hospital Based Cross-Sectional Study.

C Suhashini Karnal, S Sampathkumari, Sravani Chithra, K Alagu Sakthi Sowparnika

Abstract read
In one paragraph

Article in Journal of obstetrics and gynaecology of India, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

C Suhashini KarnalDepartment of Obstetrics and Gynaecology, Sri Muthukumaran Medical College Hospital and Research Institute, Chennai, India.
S SampathkumariDepartment of Obstetrics and Gynaecology, Sri Muthukumaran Medical College Hospital and Research Institute, Chennai, India.
Sravani ChithraDepartment of Obstetrics and Gynaecology, Sri Muthukumaran Medical College Hospital and Research Institute, Chennai, India.
K Alagu Sakthi SowparnikaDepartment of Obstetrics and Gynaecology, Sri Muthukumaran Medical College Hospital and Research Institute, Chennai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cervical cancer is the one of the most constantly diagnosed and leading cause of cancer death in women, with an estimated 604,000 new cases and 342,000 deaths worldwide. One woman dies of cervical cancer every 9 min in India. Despite its high incidence, the knowledge and awareness regarding cervical cancer and its screening is limited. This study aims to estimate the proportion of preinvasive lesions of cervix among healthy and immunocompromised individuals. Methods: An observative cross-sectional study done in a tertiary care centre from January 2021 to June 2022 among 250 normal and 250 immunocompromised individual's attending tertiary care centre. Coloscopy guided biopsy was taken for histopathological examination after informed and written consent. Results: The proportion of preinvasive lesion of cervix among 500 individuals is 8.2% (41). The proportion of preinvasive lesion among normal individuals is 5.2% (13) and among immunocompromised individual is 11.2% (28). Most of the positive cases, 46% (19) were seen in women with more than two children. 75% (31) of positive cases were seen in women who had their first coitus at age less than 21 yrs. 87.8% of positive cases were seen in women not using any method of contraception. Conclusion: Preinvasive lesions are more common in immune compromised and it is precisely clear that all women must undergo cervical cancer screening as cervical cancer is the most common among women. "Prevention is better than cure"-Screening and early treatment of preinvasive lesion is cost-effective way to prevent cancer cervix.

Indexed as

Hospital based Cross- sectional studyHPEImmunocompromisedPreinvasive lesion

Identifiers

PMID40390945
PMCPMC12085733

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.